Back to results
US 2003/0166700 A1Published application
Medicament
AssigneeSmithKline Beecham Corporation
InventorJames Hill
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the prevention of atheroma progression and the regression of atheroma.
Claims11
A method of the prevention of atheroma progression and the regression of atheroma in a mammal which comprises administering to a subject in need thereof an effective amount of an angiotensin II receptor antagonist.
Dependencies are inferred from the claim text.